Moderna is set to begin clinical testing of its experimental COVID-19 vaccine this month, positioning it to be first among a host of shots that companies are developing to fight the outbreak, reported Bloomberg.
The vaccine candidate is moving very rapidly and will enter human trials "within a couple of weeks," said Richard Hatchett, chief executive officer of the Coalition for Epidemic Preparedness Innovations (CEPI).
The estimated start of a trial of Moderna's vaccine is March 19, according to a US government website, while Hatchett indicated that Moderna's vaccine could hit Phase II testing as soon as this summer.
"We're working closely with Moderna, with our partners at [the US National Institutes of Health] and with regulators to make sure any vaccine that is developed…is safe and effective," he said.
Participants haven't yet received the vaccine, though the enrollment process has begun, the US institute said Friday, adding that the early-stage trial will be held at Kaiser Permanente Washington Health Research Institute in Seattle.
To read more NewsPoints articles, click here.